Vancomycin
"Vancomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
Descriptor ID |
D014640
|
MeSH Number(s) |
D09.400.420.925 D12.644.233.925
|
Concept/Terms |
AB-Vancomycin- AB-Vancomycin
- curasan Brand of Vancomycin Hydrochloride
Diatracin- Diatracin
- Dista Brand of Vancomycin Hydrochloride
VANCO-cell- VANCO-cell
- cell pharm Brand of Vancomycin Hydrochloride
Vanco-saar- Vanco-saar
- MIP Brand of Vancomycin Hydrochloride
Vancocin- Vancocin
- Eli Lilly Brand of Vancomycin Hydrochloride
- Vancomycin Lilly
- Lilly Brand of Vancomycin Hydrochloride
- Vancocine
- Vancocin HCl
|
Below are MeSH descriptors whose meaning is more general than "Vancomycin".
Below are MeSH descriptors whose meaning is more specific than "Vancomycin".
This graph shows the total number of publications written about "Vancomycin" by people in UAMS Profiles by year, and whether "Vancomycin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 1 | 0 | 1 | 2023 | 0 | 1 | 1 | 2021 | 3 | 3 | 6 | 2020 | 3 | 3 | 6 | 2019 | 1 | 1 | 2 | 2018 | 4 | 0 | 4 | 2017 | 1 | 1 | 2 | 2016 | 1 | 2 | 3 | 2015 | 4 | 0 | 4 | 2014 | 1 | 1 | 2 | 2012 | 2 | 0 | 2 | 2011 | 0 | 4 | 4 | 2010 | 0 | 1 | 1 | 2009 | 1 | 1 | 2 | 2008 | 0 | 1 | 1 | 2004 | 3 | 2 | 5 | 1998 | 1 | 0 | 1 | 1996 | 1 | 0 | 1 | 1990 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vancomycin" by people in Profiles over the past ten years.
-
Jung D, Kishk OA, Bhutta AT, Cummings GE, El Sahly HM, Virk MK, Moffett BS, Morris Daniel JL, Watanabe A, Fishbane N, Kotloff KL, Gu K, Ghazaryan V, Gobburu JVS, Akcan-Arikan A, Campbell JD. Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients. Crit Care Explor. 2024 Oct 01; 6(10):e1159.
-
Haynes AS, Maples H, Parker S. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):308-318.
-
McAlpine A, Robinson JL, Barton M, Balamohan A, Davies HD, Skar G, Lefebvre MA, Almadani A, Freire D, Le Saux N, Bowes J, Srigley JA, Passarelli P, Bradley J, Khan S, Purewal R, Viel-Th?riault I, Ranger A, Hawkes MT. Cerebrospinal Fluid Shunt Infections: A Multicenter Pediatric Study. Pediatr Infect Dis J. 2022 06 01; 41(6):449-454.
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rodvold KA, Maples HD. Questions on Vancomycin Dosing. Clin Infect Dis. 2021 10 05; 73(7):e1777-e1778.
-
Hoover A, Zimmerman JAO, Wiese S, Modi A. Evaluation of Empiric Vancomycin for Fevers During High-dose Cytarabine Administration. J Pediatr Hematol Oncol. 2021 Oct 01; 43(7):e1010-e1014.
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Beringer AW, Rodvold KA, Maples HD. Validity of 2020 vancomycin consensus recommendations and further guidance for practical application. Am J Health Syst Pharm. 2021 07 22; 78(15):1364-1367.
-
Jarugula P, Scott S, Ivaturi V, Noack A, Moffett BS, Bhutta A, Gobburu JVS. Understanding the Role of Pharmacometrics-Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv Software. J Clin Pharmacol. 2021 06; 61 Suppl 1:S125-S132.
-
Beenken KE, Campbell MJ, Ramirez AM, Alghazali K, Walker CM, Jackson B, Griffin C, King W, Bourdo SE, Rifkin R, Hecht S, Meeker DG, Anderson DE, Biris AS, Smeltzer MS. Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect. Sci Rep. 2021 05 13; 11(1):10254.
-
Harrison ZL, Pace LR, Brown MN, Beenken KE, Smeltzer MS, Bumgardner JD, Haggard WO, Amber Jennings J. Staphylococcal infection prevention using antibiotic-loaded mannitol-chitosan paste in a?rabbit model of implant-associated osteomyelitis. J Orthop Res. 2021 11; 39(11):2455-2464.
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro B. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2020 09 12; 71(6):1361-1364.
-
Rybak MJ, Le J, Lodise T, Levine D, Bradley J, Liu C, Mueller B, Pai M, Wong-Beringer A, Rotschafer JC, Rodvold K, Maples HD, Lomaestro BM. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. J Pediatric Infect Dis Soc. 2020 07 13; 9(3):281-284.
-
Traversa A, Hammond DA, Peksa GD, DeMott JM. Short Versus Extended Duration Vancomycin and Piperacillin/Tazobactam and the Incidence of Acute Kidney Injury in Noncritically Ill Patients. J Pharm Pract. 2021 Dec; 34(6):882-887.
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020 05 19; 77(11):835-864.
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2020 04; 40(4):363-367.
-
Shah KJ, Cherabuddi K, Pressly KB, Wright KL, Shukla A. Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges. BMC Nephrol. 2020 03 04; 21(1):76.
-
G C B, Sahukhal GS, Elasri MO. Role of the msaABCR Operon in Cell Wall Biosynthesis, Autolysis, Integrity, and Antibiotic Resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2019 10; 63(10).
-
Basco MDS, Kothari A, McKinzie PB, Revollo JR, Agnihothram S, Azevedo MP, Saccente M, Hart ME. Reduced vancomycin susceptibility and increased macrophage survival in Staphylococcus aureus strains sequentially isolated from a bacteraemic patient during a short course of antibiotic therapy. J Med Microbiol. 2019 Jun; 68(6):848-859.
-
Meeker DG, Cooper KB, Renard RL, Mears SC, Smeltzer MS, Barnes CL. Comparative Study of Antibiotic Elution Profiles From Alternative Formulations of Polymethylmethacrylate Bone Cement. J Arthroplasty. 2019 07; 34(7):1458-1461.
-
Robertson AD, Li C, Hammond DA, Dickey TA. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem. Pharmacotherapy. 2018 12; 38(12):1184-1193.
-
Velez JCQ, Obadan NO, Kaushal A, Alzubaidi M, Bhasin B, Sachdev SH, Karakala N, Arthur JM, Nesbit RM, Phadke GM. Vancomycin-Associated Acute Kidney Injury with a Steep Rise in Serum Creatinine. Nephron. 2018; 139(2):131-142.
-
Boles LR, Awais R, Beenken KE, Smeltzer MS, Haggard WO, Jessica AJ. Local Delivery of Amikacin and Vancomycin from Chitosan Sponges Prevent Polymicrobial Implant-Associated Biofilm. Mil Med. 2018 03 01; 183(suppl_1):459-465.
-
Hammond DA, James TB, Atkinson LN, Painter JT, Lusardi K. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients. Crit Care Nurse. 2018 Feb; 38(1):24-28.
-
Kattoor AJ, Rochlani YM, Kuriakose K, Meena NK. Mitral valve vegetation diagnosed with oesophageal ultrasound with bronchoscope (EUS-B). BMJ Case Rep. 2017 May 15; 2017.
-
Njoku JC, Van Schooneveld TC, Rupp ME, Olsen KM, Qiu F, Meza JL, Hermsen ED. Lack of Benefit With Combination Therapy for Clostridium difficile Infection. Infect Control Hosp Epidemiol. 2017 05; 38(5):602-605.
-
Khalid L, Ali I, Wahid K, Khan AU, Fawad S. Purple Urine Bag Syndrome. J Coll Physicians Surg Pak. 2016 Oct; 26(10):863-864.
-
Hammond DA, Smith MN, Painter JT, Meena NK, Lusardi K. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study. Pharmacotherapy. 2016 05; 36(5):463-71.
-
Jennings JA, Beenken KE, Parker AC, Smith JK, Courtney HS, Smeltzer MS, Haggard WO. Polymicrobial Biofilm Inhibition Effects of Acetate-Buffered Chitosan Sponge Delivery Device. Macromol Biosci. 2016 Apr; 16(4):591-8.
-
Albayati ZA, Sunkara M, Schmidt-Malan SM, Karau MJ, Morris AJ, Steckelberg JM, Patel R, Breen PJ, Smeltzer MS, Taylor KG, Merten KE, Pierce WM, Crooks PA. Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone. Antimicrob Agents Chemother. 2015 Dec 14; 60(3):1865-8.
-
Jennings JA, Carpenter DP, Troxel KS, Beenken KE, Smeltzer MS, Courtney HS, Haggard WO. Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm. Clin Orthop Relat Res. 2015 Jul; 473(7):2270-82.
-
Patel K, Crumby AS, Maples HD. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC? Paediatr Drugs. 2015 Apr; 17(2):97-103.
-
Samanta D, Batte JL, Brown SN, Crosby AG, Marcos LA, Elasri MO. Molecular and phenotypic characterization of methicillin-resistant Staphylococcus aureus isolates causing bacteremia at a major hospital in southern Mississippi. Am J Infect Control. 2015 May 01; 43(5):540-2.
-
Powell SL, Liebelt E. Appropriate use of vancomycin in a pediatric emergency department through the use of a standardized electronic guideline. J Pediatr Nurs. 2015 May-Jun; 30(3):494-7.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|